# Endeavour Silver Corp: financial statements, quarterly

EXK · NYSE · CIK 1277866 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exk.md) · [Financials](/companies/exk/financials.md) · [Filings](/companies/exk/filings.md) · [Insiders](/companies/exk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/exk/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.4](/filings/0001062993-18-001119.md) | [72.3](/filings/0001062993-19-001052.md) | [38.3](/filings/0001062993-20-001269.md) | [33.4](/filings/0001062993-21-002054.md) | [23.4](/filings/0001062993-22-007248.md) | [61.1](/filings/0001062993-23-008096.md) | [103](/filings/0001062993-24-006089.md) | [83.4](/filings/0001062993-25-005063.md) | [35.3](/filings/0001062993-25-005063.md) | [106](/filings/0001062993-26-001662.md) | [215](/filings/0001062993-26-001662.md) |
| Current assets | $m | not reported | [113](/filings/0001062993-18-001119.md) | [88.5](/filings/0001062993-19-001052.md) | [78.0](/filings/0001062993-20-001269.md) | [63.3](/filings/0001062993-21-002054.md) | [105](/filings/0001062993-22-007248.md) | [162](/filings/0001062993-23-008096.md) | [146](/filings/0001062993-24-006089.md) | [101](/filings/0001062993-25-005063.md) | [158](/filings/0001062993-26-001662.md) | [423](/filings/0001062993-26-001662.md) |
| Total assets | $m | not reported | [181](/filings/0001062993-18-001119.md) | [179](/filings/0001062993-19-001052.md) | [177](/filings/0001062993-20-001269.md) | [164](/filings/0001062993-21-002054.md) | [211](/filings/0001062993-22-007248.md) | [294](/filings/0001062993-23-008096.md) | [399](/filings/0001062993-24-006089.md) | [475](/filings/0001062993-25-005063.md) | [719](/filings/0001062993-26-001662.md) | [1,236](/filings/0001062993-26-001662.md) |
| Current liabilities | $m | not reported | [31.9](/filings/0001062993-18-001119.md) | [22.3](/filings/0001062993-19-001052.md) | [23.5](/filings/0001062993-20-001269.md) | [24.8](/filings/0001062993-21-002054.md) | [34.6](/filings/0001062993-22-007248.md) | [40.6](/filings/0001062993-23-008096.md) | [52.7](/filings/0001062993-24-006089.md) | [58.2](/filings/0001062993-25-005063.md) | [78.9](/filings/0001062993-26-001662.md) | [277](/filings/0001062993-26-001662.md) |
| Total liabilities | $m | not reported | [47.3](/filings/0001062993-18-001119.md) | [32.1](/filings/0001062993-19-001052.md) | [32.3](/filings/0001062993-20-001269.md) | [40.9](/filings/0001062993-21-002054.md) | [51.5](/filings/0001062993-22-007248.md) | [56.6](/filings/0001062993-23-008096.md) | [83.5](/filings/0001062993-24-006089.md) | [88.5](/filings/0001062993-25-005063.md) | [235](/filings/0001062993-26-001662.md) | [657](/filings/0001062993-26-001662.md) |
| Shareholders' equity | $m | [50.9](/filings/0001062993-18-001119.md) | [133](/filings/0001062993-19-001052.md) | [147](/filings/0001062993-20-001269.md) | [145](/filings/0001062993-21-002054.md) | [123](/filings/0001062993-22-007248.md) | [159](/filings/0001062993-23-008096.md) | [237](/filings/0001062993-24-006089.md) | [316](/filings/0001062993-25-005063.md) | [386](/filings/0001062993-26-001662.md) | [484](/filings/0001062993-26-001662.md) | [579](/filings/0001062993-26-001662.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 262,323,863 at 2025-12-31, from the cover of the [40-F filed 2026-03-30](/filings/0001062993-26-001662.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.